In SHH medulloblastomas, disrupting PRC2 activity through deletion of either Eed or Ezh2 was sufficient to allow widespread expression of genes typically suppressed by the PRC2, including the CDKN2A tumor suppressor. This evidence concerns the gene CDKN2A and neoplasm.